|
Technological
Approaches
1. The development and
validation of an uncertainty DMT
The
Decision Management Tool (DMT) will utilise
well-established methods for the estimation of
measurement uncertainty and will then employ novel
Optimised Contaminated Land Investigation (OCLI) method1
to optimise the uncertainty of on-site measurements to
promote their effective use in contaminated land
assessment.
Measurement
uncertainty (the range with which the true value lies)
arises from both the sampling procedure and the chemical
analysis2,
and has both systematic and random components. The total
uncertainty on individual on-site measurements can be
estimated by combining the random and systematic
components.
The
precision is an estimate of the random component of the
uncertainty of the measurement process and can be
estimated using the Duplicate Method3
often
applied using a balanced design:
In
this method a proportion of the sample measurements are
taken in duplicate (e.g. 10%, but not less than 8).
These duplicate samples are not taken in exactly in the
same place, but separated by a distance that represents
the ambiguity in the sampling protocol and surveying
technology (e.g. 2m in a typical site investigation).
The duplicate samples are then each analysed in
duplicate. The data produced from this balanced design
can then be analysed using the statistical technique
called robust analysis of variance (ANOVA) to separate
and quantify the contributions of sampling and analysis
to the precision.
The
systematic component of the uncertainty can be estimated
by the bias of the on-site measurement technique. This
will be estimated by a comparison between the on-site
measurements and the lab-based analysis (MCerts
accredited). These
lab-based measurements are not true values, but also
have estimates of uncertainty issued by the laboratory
(e.g. MCerts accredited), and the measurements also have
traceability, usually to certified reference materials
(CRM). The estimation of bias is made using a regression
of the on-site measurements against the lab-based values
(using a maximum likelihood approach that allows for
uncertainty on both axes).
A
sampling plan will be implemented to evaluate the
uncertainty of the measurements made with the on site
tools. It will require at least 20 sampling locations,
and a sufficient amount of soil taken at each sampling
location for on site Field Analytical Tests (FATs) and
lab analysis. A second (duplicate) sample will be taken
at 8 of the sampling locations at a distance that
represents the ambiguity in the sampling protocol. The
differences in concentration between the duplicate
samples are used to estimate the variability caused by
short-range heterogeneity, which is one component of the
whole uncertainty of measurement Robust Analysis of
Variance (RANOVA).
Once
the on site measurements have been validated in the
initial phase of investigations, routine quality control
procedures will be devised and tested, for subsequent
applications of the same ‘on site’ technique to new
sites.
The
‘Optimised Contaminated Land Investigation’ (OCLI)
Method can be used to assess the fitness-for-purpose of
an investigation by looking at the costs of the
investigation and the cost of misclassification caused
by the measurement uncertainty. The method can be used
to find the minimal expectation of loss and hence the
optimal measurement uncertainty. Comparison of the
optimal measurement uncertainty to the actual
uncertainty estimated for the investigation will give an
indication of the fitness-for-purpose of the
investigation.
2.
To develop an OUMCI field analytical tool
The
field analytical immunoassay tool will be developed to
effectively minimise uncertainty by reducing
sources
of errors. The
major sources of error are quantitative (sensitivity of
detection), qualitative (a lack of specificity producing
false positives) and operator error (addition of assay
reagent). Current
immunoassay products used in the contaminated land
sector allow the quantification of classes of compounds,
for example (PAHs)
and carcinogenic PAHs4.
The technology is well established and validated
but has significant limitations.
Current
systems have the ability to detect toxins down to the
parts per million (ppm) level, however,
key-risk drivers such as benzo(a)pyrene (BaP), often
require part per billion (ppb) detection.
The existing detection system produces a
colormetric reaction upon binding of the desired toxin
to an antibody, but this system has limited sensitivity
together with a lack of specificity of compounds
detected. Additionally,
the assay protocols require repeated rounds of user
manipulation, a source of measurement uncertainty.
The
technical approach implemented will utilise highly
sensitive chemiluminescent detection methodologies.
Chemiluminescent technologies have surpassed
conventional colormetric methods of analysis due to
their typically 100-fold increase in sensitivity, and
greater rapidity. Essentially,
a specific antibody to a toxin, labelled with alkaline
phosphatase, catalyses the decomposition of the
substrate, CDP-Star®
(Applied
Biosystems Ltd.) resulting in light generation5.
Light output will then be quantified using
photodiode and photomultiplier analysers.
The newly developed immunoassay technology will
also utilise monoclonal antibodies, for the specific
detection of key-risk drivers compounds.
Finally,
a simple microfluidic system will be constructed that
will effectively automate the immunoassay tool.
Essentially, the rapid sequential addition of
reagents and controlled mixing of components is made
possible by directing fluids through channels less than
a millimetre in diameter.
This automated system will minimise operator
error, a significant source of measurement uncertainty.


1
Taylor, P.D., Ramsey, M.H. and Potts, P.J. (2004)
Balanced measurement uncertainty against
financial benefits: a comparison of in situ and ex
situ analysis of contaminated land. Environmental Science and Technology 38: 6824-6831
2
Ramsey,
M.H. (2004) When
is sampling part of the measurement process?
Accreditation and Quality Assurance: Journal for
Quality, Comparability and Reliability in Chemical
Measurement 9, 11-12: 727-728
3
Eurachem/Eurolab/Citac/Nordtest (2006) Estimation of
measurement uncertainty arising from sampling. Draft for
consultation
4
Chuang,
J.C., Chou, Y-L, Nishioka, M., Andrews, K., Pollard, M.
and Menton, R. (1997)
Field evaluation of screening techniques for
Polycyclic Aromatic Hydrocarbons, 2,4-Diphenoxyacetic
Acid, and Pentachlorophenol in air, house dust, soil and
total diet. United
States National Exposure Environmental Protection
Research Laboratory Agency, Triangle Park, NC
27711 EPA/600/SR-97/109
5
Rongen, H.A., Hoetelmans R.M., Bult, A., van Bennekom,
W.P (1994) Chemiluminescence
and immunoassays. Journal
of Pharmaceutical and Biomedical Analysis 12(4):
433-462
Back
to top of page
|